GR3006349T3 - - Google Patents

Info

Publication number
GR3006349T3
GR3006349T3 GR920402707T GR920402707T GR3006349T3 GR 3006349 T3 GR3006349 T3 GR 3006349T3 GR 920402707 T GR920402707 T GR 920402707T GR 920402707 T GR920402707 T GR 920402707T GR 3006349 T3 GR3006349 T3 GR 3006349T3
Authority
GR
Greece
Prior art keywords
drug
resistant
infection
lactamimide
humans
Prior art date
Application number
GR920402707T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006349T3 publication Critical patent/GR3006349T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR920402707T 1988-11-10 1992-11-26 GR3006349T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26985888A 1988-11-10 1988-11-10

Publications (1)

Publication Number Publication Date
GR3006349T3 true GR3006349T3 (enExample) 1993-06-21

Family

ID=23028945

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402707T GR3006349T3 (enExample) 1988-11-10 1992-11-26

Country Status (11)

Country Link
EP (1) EP0370320B1 (enExample)
JP (1) JPH02256614A (enExample)
AT (1) ATE81004T1 (enExample)
AU (1) AU619613B2 (enExample)
DE (1) DE68903092T2 (enExample)
DK (1) DK561089A (enExample)
ES (1) ES2045348T3 (enExample)
GR (1) GR3006349T3 (enExample)
IE (1) IE893618L (enExample)
PH (1) PH27568A (enExample)
ZA (1) ZA898440B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228748A (en) * 1988-04-20 1991-07-26 Merrell Dow Pharma Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor
US5821267A (en) * 1993-10-21 1998-10-13 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
WO1995011231A1 (en) * 1993-10-21 1995-04-27 G. D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
EP0749418B1 (en) * 1994-03-10 2000-08-30 G.D. Searle & Co. L-n6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
AU712315B2 (en) * 1995-04-20 1999-11-04 G.D. Searle & Co. Cyclic amidino agents useful as nitric oxide synthase inhibitors
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
US6489323B1 (en) 1998-06-10 2002-12-03 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
JP2012502009A (ja) * 2008-09-09 2012-01-26 ビーエーエスエフ ソシエタス・ヨーロピア 動物有害生物を駆除するためのピロリン−2−イルアミノ化合物
JP5705742B2 (ja) * 2008-12-08 2015-04-22 アラーガン インコーポレイテッドAllergan,Incorporated アルファ2bまたはアルファ2bおよびアルファ2cアドレノセプターのサブタイプ選択性モジュレーターとしてのn‐(1‐フェニル‐2‐アリールエチル)‐4,5‐ジヒドロ‐3h‐ピロール‐2‐アミン化合物
WO2011042565A2 (en) * 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228130A (en) * 1978-10-23 1980-10-14 The B. F. Goodrich Company Coating polymerization reactors with oligomers derived from polyhydric phenols plus a bleach

Also Published As

Publication number Publication date
ES2045348T3 (es) 1994-01-16
ATE81004T1 (de) 1992-10-15
DK561089A (da) 1990-05-11
DE68903092T2 (de) 1993-02-18
DE68903092D1 (de) 1992-11-05
AU4445089A (en) 1990-05-17
AU619613B2 (en) 1992-01-30
EP0370320A1 (en) 1990-05-30
DK561089D0 (da) 1989-11-09
ZA898440B (en) 1990-07-25
PH27568A (en) 1993-08-18
EP0370320B1 (en) 1992-09-30
JPH02256614A (ja) 1990-10-17
IE893618L (en) 1990-05-10

Similar Documents

Publication Publication Date Title
AU2807195A (en) Hair growing agent
IE893618L (en) Lactamimides in the treatment of drug-resistant protozoal¹infections
IN170909B (enExample)
DK465488D0 (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
EP0325129A3 (en) Disubstituted pyridines
ZA899033B (en) Phenoxy and phenylthio,amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections
NZ231320A (en) Aqueous oral preparations of diclofenac
EP0495106A4 (en) Osteogenesis promoter
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
GR861529B (en) 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
ZA934971B (en) Novel phospholipid derivatives
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
IL89901A0 (en) Strobilurine derivatives
GR3005231T3 (enExample)
GB8714843D0 (en) Pharmaceutical compositions & treatments
GB8714844D0 (en) Pharmaceutical compositions & treatments